Abstract, Snapshot, Market Analysis & Market Definition: Hepatitis A Vaccine Market
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally:1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
In 2019, the market size of Hepatitis A Vaccine is 661.7 million US$ and it will reach 764.8 million US$ in 2025, growing at a CAGR of 2.1% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hepatitis A Vaccine. This report studies the global market size of Hepatitis A Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Hepatitis A Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
Market Segmentation, Outlook & Regional Insights: Hepatitis A Vaccine Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Inactivated Vaccine
Live Attenuated Vaccine
Segmentation by Application: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Government Institution
Private Sector
Other
Key Players, Recent Developments & Sector Viewpoints: Hepatitis A Vaccine Market
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac
Key Insights Covered: Exhaustive Hepatitis A Vaccine Market
1. Market size (sales, revenue and growth rate) of Hepatitis A Vaccine industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Hepatitis A Vaccine industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Hepatitis A Vaccine industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Hepatitis A Vaccine industry.
Research Methodology: Hepatitis A Vaccine Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.